The US Food and Drug Administration (FDA) has granted Fast Track Designation to Complement Therapeutics’ CTx001, the ...
About one third of lung transplant recipients have a genetic variant that makes them more likely to develop chronic lung ...
From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...
US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...
Medical University of South Carolina scientists have uncovered a link between the innate immune system and cognitive problems ...
A rare but severe stem cell transplant complication that often becomes fatal now has its first FDA-approved treatment, a therapy developed by biotechnology company Omeros. The Christmas Eve regulatory ...
In the heavy-duty truck segment, Fan said methanol-hydrogen trucks show several advantages over battery electric models: ...
A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...
Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...
Transverse colon samples from confirmed Alzheimer’s disease cases showed distinct gut microbiome and proteomic shifts, ...
Advancing investigational pre-clinical research of APL-9099 3, a potential one-time neonatal Fc receptor (FcRn) treatment ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in hidradenitis suppurativa ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback